Biotech Values

[jq1234]

I addition to the super earning, MNTA got a new drug called "generic Welbenox":

http://seekingalpha.com/article/268138-momenta-pharmaceuticals-ceo-discusses-q1-2011-results-earnings-call-transcript?source=yahoo

Craig Wheeler

Thank you, Beverly! Good morning everyone, and thank you for joining us. This morning I will discuss our company’s progress in the Q1 of 2011 and provide an update on recent corporate developments at Momenta. After that Rick will give an overview of our financials. I’ll start with a brief update on enoxaparin. After nearly ten months of the sole provider of generic Welbenox we and our collaboration partner Sandoz continue to notice strong product revenues. Due to the current status as the sole approved generic we are earning a 45% contractual profit share under our Sandoz collaboration agreement.